Packaging Corporation of America vs Revvity Inc — how do they compare? Packaging Corporation of America trades at $230.51 (market cap $20.49B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: Packaging Corporation of America is the larger of the two by market cap, and Packaging Corporation of America pays the higher dividend (2.61%). Which is the better fit depends on your goals — on Pluang, investors hold Packaging Corporation of America for 45 Days and Revvity Inc for 12 Days on average.
| PKG | RVTY | |
|---|---|---|
Market Cap | $20.49B | $16.98B |
Volume | 493,499 | 1,456,900 |
Sector | Consumer Cyclical | Health |
52-Week High | $257.43 | $157.36 |
52-Week Low | $191.68 | $82.26 |
Typical Hold Time | 45 Days | 12 Days |
Enterprise Value | $24.30B | $19.30B |
Dividend Yield | 2.61% | 0.18% |
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $230.51, up 1.43% on the day, amid a bearish technical signal from moving averages and oscillators. Recent earnings show mixed results with Q2 2026 beating estimates but Q4 2025 missing, while revenue growth is projected from $9.0B in 2025 to $9.5B in 2026. The company maintains a solid dividend, declaring $1.50 per share payable in October 2026, and analyst consensus leans hold with a $272.43 price target.
PKG faces headwinds from cost pressures and negative net cash flow, but strong institutional interest and stable packaging demand offer support. Risks include margin compression and economic sensitivity, yet the stock's current discount to analyst targets presents a potential upside for patient investors focused on fundamental strength.
Revvity (RVTY) trades at $154.18, up 0.38% today and near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for the last three quarters. Recent developments include the launch of a new diabetes screening kit in Europe and the acquisition of Human Cell Design to expand its metabolic disease research tools. Revenue remains stable around $2.9 billion, though net income margin is modest at 8.16%.
The outlook is positive with analyst consensus leaning buy (51.72%) and a price target of $132.13, though the current price exceeds it. Key opportunities include diagnostic growth and AI-driven demand, while risks involve premium valuation (P/E 73.15), margin pressures, and exposure to China market volatility. Earnings on November 3, 2026, will be critical for near-term direction.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →